# Sequential Segmental Treatment of Emphysema With Upper Lobe Predominance (STEP-UP) Study

> **NCT01719263** · NA · COMPLETED · sponsor: **Uptake Medical Corp** · enrollment: 69 (actual)

## Conditions studied

- Emphysema

## Interventions

- **DEVICE:** InterVapor® treatment plus Optimal Medical Therapy
- **OTHER:** Optimal Medical Therapy

## Key facts

- **NCT ID:** NCT01719263
- **Lead sponsor:** Uptake Medical Corp
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-06
- **Primary completion:** 2015-10
- **Final completion:** 2015-10
- **Target enrollment:** 69 (ACTUAL)
- **Last updated:** 2015-10-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01719263

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01719263, "Sequential Segmental Treatment of Emphysema With Upper Lobe Predominance (STEP-UP) Study". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01719263. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*